SCHEMBL7307343

SCHEMBL7307343

CC(C)(C)NC(=O)[C@@H]1C[C@@H](c2ccccc2)CN1C(=O)OC(C)(C)C

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTRA1 Q92743 1/20 0.63
ELANE P08246 1/20 0.46
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
HDAC8 Q9BY41 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HCRTR2 O43614 1/20 0.41
RORC P51449 2/20 0.41
TACR1 P25103 2/20 0.40
NR1H2 P55055 2/20 0.40
NR1H3 Q13133 2/20 0.40
HSD11B1 P28845 1/20 0.40
NPC1 O15118 1/20 0.40
MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30147198 0.88 HTRA1 (0.66) HTRA1ELANECYP1A2POLBCYP3A4
SCHEMBL2239296 0.86 HTRA1 (0.60) HTRA1ELANECYP1A2POLBCYP3A4
SCHEMBL4195796 0.86 HTRA1 (0.60) HTRA1ELANECYP1A2POLBCYP3A4
SCHEMBL5203691 0.86 HTRA1 (0.60) HTRA1ELANECYP1A2POLBCYP3A4
SCHEMBL5201925 0.86 HTRA1 (0.60) HTRA1ELANECYP1A2POLBCYP3A4
SCHEMBL1243964 0.86 HTRA1 (0.60) HTRA1ELANECYP1A2POLBCYP3A4
SCHEMBL205497 0.86 HTRA1 (0.60) HTRA1ELANECYP1A2POLBCYP3A4
SCHEMBL1782234 0.86 HTRA1 (0.60) HTRA1ELANECYP1A2POLBCYP3A4
SCHEMBL9543379 0.86 HTRA1 (0.60) HTRA1ELANECYP1A2POLBCYP3A4
SCHEMBL5206918 0.86 HTRA1 (0.60) HTRA1ELANECYP1A2POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed